Legal and Ethical Considerations in Marketing, Product Safety, and Essay

Legal and Ethical Con viewrations in Marketing, Product Safety, and Intellectual Property - demonstrate ExampleThis is sound honest behavior, even if such reporting will result in direful financial loss to the company. All of the issues and more are covered in this case study. It is important to look at the reality of direct-to-consumer (DTC) marketing by consumer and its potential impact. This paper will analyze such issues in the place setting of PharmaCARE, while also exploring intellectual property considerations and U.S. law. The backdrop to this dialogue will be a healthful consideration of the ethical obligations that a company like PharmaCARE has to the global community. Direct to Consumer Marketing and Drug Companies merely put, direct to consumer marketing involves the promotion of a product in mainstream media. The intent is to promote the product by appealing the potential consumer straightaway. The term is actually most commonly applied to the pharmaceutical indu stry, which makes it worthy of handling in this case. Drug companies that engage in direct to consumer marketing bypass health professionals and attempt to orbital cavity the patient directly. The Federal Food and Drug Administration regulate such advertising, yet many professionals necessitate that the oversight is quite lax and ineffective. There are several concerns with this method of advertising that applies particularly in the case of PharmaCARE. It should be noned that the most common methods of direct to consumer marketing include television advertising, print, radio, and instantaneously social media outlets. With the lack of adequate oversight, questions of an ethical nature are frequently asked when considering whether or not medicate companies should use such a marketing strategy. Advertising companies are not health professionals. They do not diagnose patients and they cannot adequately determine if the side effects of any given drug may be counterproductive for t he consumer. While pharmaceutical companies are required by law to indicate potential side effects of the drug being marketing, and they are only permitted to tout proven benefits of the medicine, such disclaimers are a lot not clear to the consumer. This can lead individual patients to try and self-diagnose their give illnesses, and then approach their own physician about getting a particular drug consecrated to them. This leads us to yet another(prenominal) ethical dilemma. If an advertising campaign for a new drug floods the airwaves, physicians may become inundated with requests to prescribe the drug to their patients. This puts the physician in an awkward position. They may end up overprescribing the drug, doing so without themselves actually researching the drug and feeling comfortable in its use. This creates the ethical question of whether drug companies should even be permitted to engage this pattern at all. The argument is that they should only allowed to promote their products directly to health care professions, who can then sink which drugs best suit their particular patients. The practice of direct to consumer pharmaceutical advertising (DTCPA) has so many ethical implications that most countries have an outright ban on the practice. Only the United States and New Zealand permit its freehanded use. This is the reason that PharmaCARE has been permitted to engage in the practice. To be fair, not at all pharmaceutical companies market their drugs directly to the consumer. It seems to be